Related Experiment Video
Updated: Jul 13, 2026

08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Novel treatments for cancer cachexia.
Maurizio Bossola1, Fabio Pacelli, Giovan Battista Doglietto
1Catholic University of the Sacred Heart, Department of Surgery, Largo A. Gemelli, Roma, Italy. maubosso@tin.it
Expert Opinion on Investigational Drugs
|August 10, 2007
Summary
Cancer cachexia, marked by muscle wasting and appetite loss, significantly impacts cancer patient outcomes. New pharmacological approaches aim to counteract these effects, showing promise in early trials.
Area of Science:
- Oncology
- Metabolic Disorders
- Muscle Physiology
Background:
- Cancer cachexia is a complex syndrome causing significant mortality in cancer patients.
- It is characterized by anorexia, body weight loss, and severe muscle wasting.
- Muscle wasting, driven by hyperactive proteolytic pathways, impairs patient function and treatment response.
Purpose of the Study:
- To explore novel therapeutic strategies for cancer cachexia.
- To investigate pharmacological interventions targeting anorexia, catabolism, and anabolism in muscle.
Main Methods:
- Review of recent pharmacological attempts to correct anorexia.
- Analysis of studies inhibiting muscle catabolic processes.
- Evaluation of strategies stimulating anabolic pathways in skeletal muscle.
Main Results:
- Existing therapies for cancer cachexia show limited efficacy.
- Pharmacological interventions have demonstrated encouraging results in preclinical models.
- Preliminary clinical trials suggest potential benefits of these new approaches.
Conclusions:
- Targeting anorexia, muscle catabolism, and anabolism offers a promising therapeutic avenue for cancer cachexia.
- Further research and clinical trials are warranted to validate these pharmacological strategies.
- Improved management of cancer cachexia could enhance patient quality of life and treatment outcomes.
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...